CDH1 and adenocarcinoma: Although E-cadherin immunostaining was broadly positive in all three groups, the IHS scoring demonstrated a stepwise reduction in expression from normal mucosa to adenocarcinoma (P=0.004), and from adenocarcinoma to PMP (P=0.006).